AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in BTK Inhibitor Therapy for Mantle Cell Lymphoma
This chapter delves into the latest developments in BTK inhibitors for mantle cell lymphoma, focusing on their role as standard care for relapsed patients. It highlights the ECHO trial's promising results and discusses the selection, side effects, and resistance management strategies associated with these therapies.